TYP Price sensitive 12 Aug 2025, 8:29 AM

$2.6m in non-dilutive capital funding secured

Tryptamine Therapeutics Ltd

Sign in to open PDF

No summary is available for this announcement — sign in to read the PDF in full.

Sign in for more about this company, including guidance changes and other insights.
Sign in